These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6180075)

  • 21. Antitumor effect of human fibroblast interferon on the growth of human melanoma cells implanted in nude mice.
    Ida N; Uenishi N; Kajita A; Satoh Y
    Gan; 1982 Dec; 73(6):952-60. PubMed ID: 7160584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.
    Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H
    J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly sensitive enzyme immunoassay of human interferon-beta 1.
    Yamazaki S; Kuramoto K; Matsuo E; Hosoi K; Hara M; Shimizu H
    J Immunoassay; 1989; 10(1):57-73. PubMed ID: 2654186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies against human beta interferon following treatment with interferon.
    Vallbracht A; Treuner J; Manncke KH; Niethammer D
    J Interferon Res; 1982; 2(1):107-10. PubMed ID: 6180097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Administration of human interferon to rabies virus-infected monkeys after exposure.
    Hilfenhaus J; Weinmann E; Majer M; Barth R; Jaeger O
    J Infect Dis; 1977 May; 135(5):846-9. PubMed ID: 404370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon system of human cornea cells: interferon production, characterization, and development of antiviral state.
    Thacore HR; Mount DT; Chadha KC
    J Interferon Res; 1982; 2(3):401-8. PubMed ID: 6182255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon activity and its characterization in the sera of patients with premalignant lesions arising in oral mucosa.
    Urata M; Yoshida H; Yanagawa T; Yura Y; Furumoto N; Azuma M; Hayashi Y; Sato M
    Int J Oral Maxillofac Surg; 1986 Apr; 15(2):134-47. PubMed ID: 2420904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. American cancer society Phase I trial of naturally produced beta-interferon.
    Hawkins MJ; Krown SE; Borden EC; Krim M; Real FX; Edwards BS; Anderson SA; Cunningham-Rundles S; Oettgen HF
    Cancer Res; 1984 Dec; 44(12 Pt 1):5934-8. PubMed ID: 6498851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An interferon-beta-like or interferon-inducing protein released by mitogen-stimulated human leukocytes.
    Van Damme J; Billiau A; De Ley M; De Somer P
    J Gen Virol; 1983 Aug; 64 (Pt 8)():1819-22. PubMed ID: 6875520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of rat fibroblast interferon.
    Abreu SL
    J Pharmacol Exp Ther; 1983 Jul; 226(1):197-200. PubMed ID: 6191024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of human fibroblast interferon (HuIFN-beta) on the growth and invasive potential of cultured human melanoma cells in vitro.
    Fukuzawa K; Horikoshi T
    Br J Dermatol; 1992 Apr; 126(4):324-30. PubMed ID: 1571252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin.
    Chiang J; Gloff CA; Yoshizawa CN; Williams GJ
    Pharm Res; 1993 Apr; 10(4):567-72. PubMed ID: 8483840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The preparation of antibodies directed against human immune interferon.
    De Ley M; Van Damme J; Billiau A; De Somer P
    J Virol Methods; 1981 Oct; 3(3):149-53. PubMed ID: 6170651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of recombinant alpha A interferon following I.V. infusion and bolus, I.M., and P.O. administrations to African green monkeys.
    Wills RJ; Spiegel HE; Soike KF
    J Interferon Res; 1984; 4(3):399-409. PubMed ID: 6491397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-tumor activity of human recombinant TNF against human malignant glioma cell lines and combined effect with Hu INF-beta].
    Enomoto H; Yoshida J; Kageyama N; Ueda R; Kato T; Ota K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1953-61. PubMed ID: 3085596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of human leukocyte interferon.
    Cantell K; Pyhälä L
    J Infect Dis; 1976 Jun; 133 Suppl():A6-12. PubMed ID: 932506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicity studies with human fibroblast interferon.
    Ronneberger H; Hilfenhaus J
    Arch Toxicol Suppl; 1983; 6():391-4. PubMed ID: 6578747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human biologic response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-beta serine.
    Goldstein D; Sielaff KM; Storer BE; Brown RR; Datta SP; Witt PL; Teitelbaum AP; Smalley RV; Borden EC
    J Natl Cancer Inst; 1989 Jul; 81(14):1061-8. PubMed ID: 2472488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of bacteria-produced human alpha, beta, and gamma interferons on in vitro immune functions.
    Shalaby MR; Weck PK; Rinderknecht E; Harkins RN; Frane JW; Ross MJ
    Cell Immunol; 1984 Apr; 84(2):380-92. PubMed ID: 6231112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic study of liposome-encapsulated human interferon-gamma after intravenous and intramuscular injection in mice.
    Rutenfranz I; Bauer A; Kirchner H
    J Interferon Res; 1990 Jun; 10(3):337-41. PubMed ID: 2117038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.